Cited by 108Gut microbiota and healthMetabolomics and Mass Spectrometry StudiesMicrobial Natural Products and Biosynthesis

Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery

Open access
Brown, J. Mark, Hazen, Stanley L.·2017·Journal of Biological Chemistry

Abstract

Recent advances in metabolomic and genome mining approaches have uncovered a poorly understood metabolome that originates solely or in part from bacterial enzyme sources. Whether living on exposed surfaces or within our intestinal tract, our microbial inhabitants produce a remarkably diverse set of natural products and small molecule metabolites that can impact human health and disease. Highlighted here, the gut microbe-derived metabolite trimethylamine N -oxide has been causally linked to the development of cardiovascular diseases. Recent studies reveal drugging this pathway can inhibit atherosclerosis development in mice. Building on this example, we discuss challenges and untapped potential of targeting bacterial enzymology for improvements in human health.

Integrity signals

Registry

Crossref · 10.1074/jbc.r116.765388

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Brown, J. M., & Hazen, S. L.
Affiliations
Cleveland Clinic (US)
Corresponding author
  • Brown, J. Mark
  • Hazen, Stanley L.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2017-05
Volume
292
Issue
21
Pages
8560-8568
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2605025237
Cited by
108
References
32
Citations by year
2026: 4 · 2025: 7 · 2024: 6 · 2023: 12 · 2022: 18 · 2021: 11 · 2020: 16 · 2019: 12 · 2018: 15 · 2017: 6
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Foundation for the National Institutes of Health (R01 HL122283, P50 AA024333, R01 HL103866, P01 HL076491, R01DK10600, R01HL126827)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Health Sciences › Medicine › Pharmacology › Microbial Natural Products and Biosynthesis
Keywords
microbial metabolites, bacterial enzymes, drug discovery, trimethylamine N-oxide, gut microbiota, cardiovascular disease, atherosclerosis, metabolomics, genome mining, natural products, human health
MeSH terms
Gastrointestinal Microbiome, Animals, Humans, Methylamines, Atherosclerosis, Mice, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review